// Learn · Brand Review

Kreleaf Review (2026): Lab Data, Pricing, and the August 5 Question

Reviewed: July 14, 2026 · every claim checked against Kreleaf's live site and primary federal documents

Quick verdict

Kreleaf is a real, documentation-forward vendor — batch-dated COAs from two named labs, per-product lab pages, alkaloid content printed on every listing, card payments, and a 21+ gate. It scored 9/12 in our 12-brand transparency audit, second overall. The defining fact of any 2026 Kreleaf review, though, is the calendar: by our count, every product line it sells except MIT, SR-17018, and accessories is named in one of the two DEA scheduling notices that can take effect August 5, 2026.

"Kreleaf review" searches mostly surface automated scam-checker pages that score the domain and stop there. This is the other kind of review: we read every product page, pulled the published batch data, did the price-per-milligram math, and mapped the catalog against the two Federal Register notices — so you can judge the company on facts rather than a trust score.

What Kreleaf is

Kreleaf (kreleaf.com) is a US online retailer of concentrated kratom-alkaloid products under the tagline "Clinical Purity. Botanical Integrity. Professional Grade." The catalog spans seven lines: 7-OH dominant tablets in 22 listed flavors, sublingual 7-OH strips, high-purity 7-OH/pseudo powders, pseudoindoxyl-only tablets and powder, an MGM-15 powder, a mitragynine (MIT) tablet-and-shot line, and an SR-17018 line — plus scales, kits, and gift cards. It advertises free shipping at $100+, free second-day at $120+, free overnight at $400+, and same-day dispatch for orders before 2:30pm PT. The site runs a birthday-entry 21+ age gate and carries the standard FDA disclaimer, and it hosts its own customer community ("KreHouse").

The product wall, mapped against the DEA notices

On July 6, 2026 the DEA published two notices of intent in the Federal Register: 2026-13580 (temporary Schedule I for 7-hydroxymitragynine above 0.05% concentration or 1.00 mg per article) and 2026-13581 (temporary Schedule I for mitragynine pseudoindoxyl, MGM-15, and MGM-16). Final orders can take effect August 5, 2026 at the earliest — our ban status tracker follows the dates. Here is Kreleaf's lineup against those two documents, using its own published prices and batch data:

Product lineCompoundList price (July 2026)Named in a DEA notice?
7-OH dominant tablets (22 flavors listed)7-hydroxymitragynine (5.53–98.67 mg listed alkaloids per tablet)$12.19–$31.49 per 5-pack (homepage list prices)Yes — 2026-13580 (above the 0.05% / 1.00 mg threshold)
Mint sublingual strips7-OH (37.84 mg per strip, per published batch data)$22.79 per 5-packYes — 2026-13580
7-OH / pseudo blend powders (7 listed)7-OH with minor pseudoindoxyl (533–1,000 mg alkaloids per gram)$29.99–$74.99 from-prices (1-gram base size)Yes — 2026-13580; pseudo content also in 2026-13581
Pseudo-only tablets (2 flavors)Mitragynine pseudoindoxyl (7.58 / 17.42 mg per tablet)From $8.69 (10-pack) / $9.99 (5-pack)Yes — 2026-13581 (pseudoindoxyl named directly)
Pure Pseudo PowderMitragynine pseudoindoxyl (859.54 mg per gram)From $84.99 per gramYes — 2026-13581
MGM-15 "DHM" powderMGM-15 / dihydro-7-hydroxymitragynine (892.75 mg per gram)From $79.99 per gramYes — 2026-13581 (MGM-15 named directly)
MIT tablets and shots (4 products)Mitragynine (49–87 mg per tablet; 146–155 mg per shot)$9.99–$12.49No — mitragynine is not scheduled by either notice
SR-17018 "SR Powder"SR-17018 (a synthetic research compound, not a kratom alkaloid)From $54.99 per gramNo — not named in either notice
OR Reset tabletsSR-17018 (50 mg) + L-tyrosine, L-theanine, GABA (supplier-stated)$11.99 per 3-tablet packNo — not named in either notice
Accessories (scales, kits, gift cards)Varies (e.g., $30.99 scale)No

Read the last column top to bottom and the August 5 exposure is stark: the 7-OH tablets, strips, and powders all carry well above 1.00 mg per article (Kreleaf's own lab pages list 5.53 mg to 98.67 mg per tablet and up to 996.81 mg of 7-OH per gram of powder), the pseudo products are built on a compound 2026-13581 names directly, and the MGM-15 powder is sold under the exact name that appears in the notice. What survives a final order unchanged: the four MIT products, the SR-17018 line, and the accessories shelf.

Lab testing: what Kreleaf publishes, and the gaps

This is the strongest part of Kreleaf's operation, and it deserves plain credit. The site maintains a Product Labs index with a dedicated lab page per product. Each product page carries a "Batch Details" block with a batch date and a full alkaloid breakdown — 7-OH, pseudoindoxyl, and mitragynine quantified separately, plus a residual-solvents pass/fail. Kreleaf states that every batch is tested by two third-party labs with a sensible division of labor: PharmLabs analyzes finished tablets after pressing, and Cora Science — an ISO/IEC 17025-accredited laboratory whose reports also appear elsewhere in this category — analyzes powders before pressing. Publishing both, with dates, is more than most of the twelve brands in our transparency report do; it is why Kreleaf scored 9/12 there.

The gaps, all checkable: the lab's accreditation status is not stated on every certificate; some batch data on live listings is aging (the mint strips page showed a November 2025 batch in July 2026); the SR-17018 line lists a single lab rather than two; and OR Reset carries only a supplier-provided COA hosted on an external LIMS, with ingredients "as stated by Supplier" — a materially weaker chain of custody than Kreleaf's own dual-lab products. And as of July 14, 2026, the independent retail-testing program TestMyKratom lists no Kreleaf products in its results database — we checked the results table and brand index directly — so there is currently no brand-independent verification of the label numbers. None of that is an accusation; it is the difference between documentation you can verify end-to-end and documentation you take on the vendor's word. Our ISO 17025 guide explains how to check a COA in five minutes.

Pricing: the per-milligram math

Kreleaf lists alkaloid content on every product, which makes honest unit math possible — something most vendors' pricing pages do not allow. Using Kreleaf's July 2026 list prices at the smallest size we could verify, and its own published per-unit alkaloid figures:

Product (published alkaloids)Smallest verified sizeList-price cost per mg
Artemis powder (840 mg/g)1 gram — $34.99≈ 4.2¢ / mg total alkaloids
Tiger's Eye powder (996.81 mg 7-OH/g)1 gram — $69.99≈ 7.0¢ / mg 7-OH
Crème Brûlée powder (955.75 mg 7-OH/g)1 gram — $74.99≈ 7.8¢ / mg 7-OH
MGM-15 powder (892.75 mg/g)1 gram — $79.99≈ 9.0¢ / mg MGM-15
Pure Pseudo Powder (859.54 mg/g)1 gram — $84.99≈ 9.9¢ / mg pseudoindoxyl
Birthday Cake tablets (39.1 mg 7-OH each)5-pack — $19.49≈ 10.0¢ / mg 7-OH
Pseudo Blue Blue Razz tablets (17.42 mg each)5-pack — $9.99≈ 11.5¢ / mg pseudoindoxyl
Mint strips (37.84 mg 7-OH each)5-pack — $22.79≈ 12.0¢ / mg 7-OH
Mango MIT tablets (87.42 mg MIT each)5-pack — $10.99≈ 2.5¢ / mg mitragynine
Lemon MIT shot (146.1 mg MIT)1 bottle — $9.99≈ 6.8¢ / mg mitragynine

The pattern: bulk powders are the value tier (4–8¢ per mg), finished tablets and strips run 10–12¢ per mg, and the specialty compounds (pseudo, MGM-15) price at a premium per milligram despite being powders. Two current discounts change the effective numbers: the sitewide 20% "DEA Comment Sale" on orders over $80 (Birthday Cake tablets drop to roughly 8¢ per mg of 7-OH) and a further 5% for crypto payment. For market context, the independent tester TestMyKratom advertises its own house tablets at 4.7–4.9¢ per mg — so Kreleaf's tablet pricing is mid-market, not bargain-tier, with its powders closing most of the gap. Larger pack sizes (25/50-packs, 5–20 gram jars) lower per-mg costs further; we computed only the base sizes we could verify on the product pages.

The DEA response: comment drive, card rails, and a cease-operations pledge

Kreleaf's posture toward the federal action is unusually explicit for this market, and worth recording verbatim. The homepage runs a banner: "20% Off 'DEA Comment' Sale is LIVE NOW" — framed as fighting "the DEA's recent move to schedule 7OH and kratom alkaloids," directing customers to submit public comments via 7hopealliance.org/federal (with a note to include daily intake), and inviting them to "stock up and prepare in case access changes." Alongside the advocacy, the site states plainly: "We comply with all laws. If kratom or 7-OH is federally banned, operations will cease immediately." That single sentence is the most important line on the site for anyone evaluating the brand in July 2026: by Kreleaf's own statement, a final scheduling order ends the catalog you see today, minus the MIT and SR lines. The recent addition of card processing (Visa, AMEX, Discover per the site banner, joining the 5%-discounted crypto rails) cuts checkout friction — it does not change the regulatory math.

How to verify any brand — Kreleaf included

Do not take this review, or any vendor's marketing, on faith. The checks are fast: match the batch number on packaging to a published COA; confirm the lab is named and look up its ISO/IEC 17025 accreditation on the accreditor's registry; check the report date against the batch you are actually buying; confirm the alkaloid numbers on the COA match the label; and look for a restricted-state list that reflects current law. Our lab-testing guide and 9-point quality checklist walk through every step. Kreleaf passes more of these checks than most of the field — which is exactly why the checks are worth running on everyone else.

If you're comparing options

Two companion pages carry the comparison work: the 2026 transparency report scores Kreleaf against eleven other brands on identical documentation criteria, and the legal 7-OH alternatives guide separates the product categories that genuinely sit outside the DEA action from the ones — pseudoindoxyl, MGM-15, MGM-16 — that are the same regulatory exposure under a different name. If your real question is "what happens next," the ban status tracker is updated whenever a filing or effective date moves.

Frequently asked questions

Is Kreleaf legit?
Kreleaf is an operating online retailer, not a phantom storefront. As of July 14, 2026 it publishes batch-dated certificates of analysis from two named third-party labs (PharmLabs and Cora Science), lists alkaloid content per tablet or gram on every product page, runs a 21+ age gate, accepts major credit cards, and posts an FDA disclaimer. In our July 2026 transparency audit of 12 brands it scored 9/12 — second place. The open question about Kreleaf is not whether it is real; it is that most of its catalog is built on compounds named in the DEA scheduling notices that can take effect August 5, 2026.
Does Kreleaf publish COAs and lab results?
Yes. Kreleaf maintains a Product Labs index with a dedicated lab page per product, and each product page carries a dated batch-details block. It states that every batch is tested by two third-party labs: PharmLabs analyzes finished tablets after pressing, and Cora Science — an ISO/IEC 17025-accredited laboratory — analyzes powders before pressing. Gaps we noted: the lab’s accreditation is not stated on every certificate, the SR-17018 line lists only one lab, and OR Reset relies on a supplier-provided COA rather than Kreleaf’s own dual-lab testing.
Is Kreleaf banned? What happens August 5, 2026?
Kreleaf is not banned as of July 14, 2026, and neither is 7-OH federally. But most of Kreleaf’s catalog — its 7-OH tablets, strips, and powders (Federal Register document 2026-13580), plus its pseudoindoxyl and MGM-15 products (document 2026-13581) — is named in the DEA’s two temporary scheduling notices, which can take effect August 5, 2026 at the earliest. Kreleaf’s own site says: "We comply with all laws. If kratom or 7-OH is federally banned, operations will cease immediately." Its mitragynine (MIT) line and SR-17018 products are not named in either notice.
Is Kreleaf shutting down?
Kreleaf has not announced a shutdown. Its homepage states it complies with all laws and that operations will cease immediately if kratom or 7-OH is federally banned. As of July 2026 it is running a "20% Off DEA Comment Sale" on orders over $80, encouraging customers to submit public comments and, in its words, "stock up and prepare in case access changes." Whether any shutdown happens depends on whether the DEA issues final orders on or after August 5, 2026.
What payment methods does Kreleaf accept?
As of July 2026, Kreleaf’s site banner says it now accepts Visa (credit/debit), American Express, and Discover, and offers 5% off for crypto payments via CashApp or Strike, with a BTCPay tutorial for direct bitcoin checkout. Card acceptance is worth noting because many vendors in this category are crypto-only or rely on workarounds.
What are the alternatives to Kreleaf?
That depends on what you mean. For other 7-OH brands, compare published documentation first — our 2026 transparency report scores 12 brands on identical criteria, and Kreleaf placed second behind Favor’d Alkz. For products that remain lawful if the DEA orders take effect, the durable categories are kratom leaf, mitragynine-based products, and sub-threshold botanicals; products marketed as "legal alternatives" that contain pseudoindoxyl, MGM-15, or MGM-16 are named in the same federal action. Our legal 7-OH alternatives guide maps the categories.

Disclosure: Wholesome Fraction has business relationships with companies in this category, including Favor'd Alkz, a Kreleaf competitor. This review contains no paid placements. Every factual claim above comes from Kreleaf's public website (retrieved July 14, 2026), the Federal Register, or the cited third-party sources, and every one of them is checkable by anyone with a browser. If you represent Kreleaf and something here is outdated, email hello@wholesomefraction.com with links and we'll re-review.

For adults 21+ only. This page is an educational review of publicly available documentation and pricing. It is not a recommendation to purchase, use, or stockpile any product, and it makes no claims about any product's effects, safety, or quality. Prices, promotions, and batch data reflect Kreleaf's site as of July 14, 2026 and will change.

These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Federal and state legal status can change quickly — verify current law before purchasing. Primary documents: Federal Register 2026-13580 and 2026-13581 at federalregister.gov.